pharma · Androgenetic Alopecia · Acute Myocardial Infarction
Dong Wang
Dong Wang trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 8
- Drugs
- 13
- Patents
- 0
Dong Wang clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Dong Wang programs — each row shows trial ID, program name, phase, status, and indication.
Dong Wang trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Dong Wang.
-
Telmisartan/Amlodipine — Phase 3
Clinical update -
rivastigmine patch — Unknown
Clinical update -
Risedronate Sodium 35 MG [Actonel] — Approved
Clinical update -
De-escalation strategy — Approved
Clinical update -
Aricept 5mg Tablet — Phase 1
Clinical update -
DA-4001C — Phase 2
Clinical update -
evogliptin — Phase 3
Clinical update -
DA-5210 10/500mg — Phase 1
Clinical update